Wird geladen...
Organizing pneumonia in ALK+ lung adenocarcinoma treated with ceritinib: A case report and literature review
RATIONALE: Anaplastic lymphoma kinase (ALK) inhibitors have been approved for patients with ALK-rearrangement lung cancer. The effect is superior to the standard first-line therapy of pemetrexed plus platinum-based chemotherapy. However, ALK inhibitors are associated with rare and sometimes fatal ad...
Gespeichert in:
| Veröffentlicht in: | Medicine (Baltimore) |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Lippincott Williams & Wilkins
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8257840/ https://ncbi.nlm.nih.gov/pubmed/34190169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000026449 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|